Guy first became involved with the UEA when he worked for AstraZeneca. One of the University’s PhD projects was co-sponsored by AstraZeneca and Guy was the external supervisor for the PhD student, whose project involved the development of an ocular toxicity model.
Guy was subsequently invited to become a lecturer on the Pharmacology and Drug Discovery BSc course and teaches the Advanced Drug Discovery, Pharmacology and Toxicology module. He also recently joined the School of Pharmacy Industrial Advisory Panel, which comprises industry experts and supports the School’s strategic decision making around curriculum design, policies on placements, assessment, and enhancing employability of graduates and research capabilities.
Dr Richard Knight Director and Co-founder of ApconiX commented, “We were absolutely delighted by Guy’s appointment at UEA, which recognises not only his reputation in pharmaceutical safety but also his dedication to helping the next generation of scientists”.